Role of Genetic Polymorphisms in the Development of Nonalcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH)

被引：0
|
作者：
Bril, Fernando [1 ,2 ]
Kawaguchi-Suzuki, Marina [1 ]
Frye, Reginald [1 ]
Sanchez, Paola Portillo [1 ,2 ]
Maximos, Maryann [1 ]
Lai, Song [3 ]
Hardies, Jean [4 ]
Tio, Fermin [4 ]
Cusi, Kenneth [1 ,2 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Malcom Randall VA Med Ctr, Gainesville, FL USA
[3] Univ Florida, CTSI Human Imaging Core McKnight Brain Inst, Gainesville, FL USA
[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
799
引用
下载
收藏
页码：585A / 585A
页数：1
相关论文
共 50 条
  • [21] Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD)
    Doycheva, Iliana
    Loomba, Rohit
    ADVANCES IN THERAPY, 2014, 31 (01) : 30 - 43
  • [22] Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
    Sulaiman, Siti Aishah
    Dorairaj, Vicneswarry
    Adrus, Muhammad Nafiz Haidi
    BIOMEDICINES, 2023, 11 (01)
  • [23] Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD)
    Iliana Doycheva
    Rohit Loomba
    Advances in Therapy, 2014, 31 : 30 - 43
  • [24] Longitudinal Analyses of Comorbidities and Healthcare Costs Among Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease
    Harrison, Stephen A.
    Kachru, Nandita
    Parker, Emily
    Korrer, Stephanie
    Loomba, Rohit
    HEPATOLOGY, 2018, 68 : 572A - 573A
  • [25] VASCULAR FUNCTION CHANGES IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)/ NONALCOHOLIC STEATOHEPATITIS
    Jafari, Kaveh
    Paquet, Veronique
    Addour, Saliha
    Fortie, Catherine
    Trepan, Gabrielle
    Ferlan, Stephanie
    Agharazii, Mohsen
    Carre, Anne-Marie
    JOURNAL OF HYPERTENSION, 2024, 42
  • [26] The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis
    Papatheodoridi, Alkistis-Maria
    Chrysavgis, Lampros
    Koutsilieris, Michael
    Chatzigeorgiou, Antonios
    HEPATOLOGY, 2020, 71 (01) : 363 - 374
  • [27] PATHOGENETIC ANALYSIS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MULTI-CELL-LINEAGE HUMAN LIVER ORGANOIDS
    Zhang, Wenjun
    Park, Yujin
    Thadasina, Deepthi
    Thi Minh Uyen Le
    Li, Ping
    Ekser, Burcin
    HEPATOLOGY, 2023, 78 : S1121 - S1122
  • [28] Prevalence and predictors of de novo nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) after orthotopic liver transplantation (OLT)
    Seo, Suk
    Maganti, Kalyani
    Khehra, Manjit
    Ramsamooj, Rajendra
    Tsodikov, Alexander
    Torok, Natalie
    GASTROENTEROLOGY, 2006, 130 (04) : A789 - A789
  • [29] Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)
    Wen, Xuerong
    Wang, Shuang
    Taveira, Tracey H.
    Akhlaghi, Fatemeh
    PLOS ONE, 2021, 16 (09):
  • [30] Effect of Roux-en-Y Reconstruction on Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Kashihara, Hideya
    Yoshikawa, Kozo
    Higashijima, Jun
    Nishi, Masaaki
    Takasu, Chie
    Shimada, Mitsuo
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E58 - E59
12345